Shopping Cart
- Remove All
Your shopping cart is currently empty
Anti-Influenza B (B/Florida/04/06) Hemagglutinin/HA Antibody (5D484)
😃Good
Catalog No. TMAY-01556
Anti-Influenza B (B/Florida/04/06) Hemagglutinin/HA Antibody (5D484) is a Rabbit antibody targeting Influenza B (B/Florida/04/06) Hemagglutinin/HA. Anti-Influenza B (B/Florida/04/06) Hemagglutinin/HA Antibody (5D484) can be used in ELISA,WB.
Anti-Influenza B (B/Florida/04/06) Hemagglutinin/HA Antibody (5D484)
Anti-Influenza B (B/Florida/04/06) Hemagglutinin/HA Antibody (5D484)
😃Good
Catalog No. TMAY-01556
Anti-Influenza B (B/Florida/04/06) Hemagglutinin/HA Antibody (5D484) is a Rabbit antibody targeting Influenza B (B/Florida/04/06) Hemagglutinin/HA. Anti-Influenza B (B/Florida/04/06) Hemagglutinin/HA Antibody (5D484) can be used in ELISA,WB.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 20 μL | $94 | 7-10 days | |
| 100 μL | $292 | 7-10 days |
Add to Cart
Add to Quotation
Bulk & Custom
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
View MoreResource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
| Description | Anti-Influenza B (B/Florida/04/06) Hemagglutinin/HA Antibody (5D484) is a Rabbit antibody targeting Influenza B (B/Florida/04/06) Hemagglutinin/HA. Anti-Influenza B (B/Florida/04/06) Hemagglutinin/HA Antibody (5D484) can be used in ELISA,WB. |
| Ig Type | Rabbit IgG |
| Clone | 5D484 |
| Specificity | Influenza B (B/Florida/04/06) HA Has cross-reactivity in ELISA and WB with Influenza B (B/Austria/1359417/2021)(Victoria lineage) HA Influenza B (B/Brisbane/60/2008) HA Influenza B (B/Colorado/06/2017) HA Influenza B (B/Florida/4/2006) HA Influenza B (B/PHUKET/3073/2013) HA Influenza B (B/Washington/02/2019) HA Medium/Minimal cross-reactivity in ELISA with H3N2 (A/Hong Kong/2671/2019) HA No cross-reactivity in ELISA and WB with H1N1 (A/Brisbane/02/2018) HA H1N1 (A/California/04/2009) HA H1N1 (A/California/07/2009) HA H1N1 (A/Guangdong-Maonan/SWL1536/2019) / (A/Hawaii/70/2019) HA H1N1 (A/Michigan/45/2015) HA H1N1 (A/Puerto Rico/8/1934) HA H1N1 (A/Wisconsin/67/2022) HA H1N1 (A/Wisconsin/67/2022) HA Trimer H1N1 (A/Wisconsin/588/2019) / (A/Victoria/2570/2019) HA H1N1 (A/Victoria/4897/2022) HA H3N2 (A/Brisbane/10/2007) HA H3N2 (A/Cambodia/e0826360/2020) HA H3N2 (A/Darwin/9/2021) HA H3N2 (A/Darwin/6/2021) HA H3N2 (A/Hong Kong/45/2019) HA H3N2 (A/Hong Kong/4801/2014) HA H3N2 (A/Kansas/14/2017) HA H3N2 (A/Singapore/INFIMH-16-0019/2016) HA H3N2 (A/Switzerland/9715293/2013) HA No cross-reactivity in ELISA with H1N1 (A/Wisconsin/67/2022) HA H2N2 (A/Canada/720/2005) HA H3N2 (A/Massachusetts/18/2022; A/Thailand/8/2022) HA H4N6 (A/mallard/Ohio/657/2002) HA H5N1 (A/Anhui/1/2005) HA H6N1 (A/northern shoveler/California/HKWF115/2007) HA H7N7 (A/Netherlands/219/03) HA H8N4 (A/pintail duck/Alberta/114/1979) HA H9N2 (A/Hong Kong/1073/99) HA H10N3 (A/duck/Hong Kong/786/1979) HA H11N2 (A/duck/Yangzhou/906/2002) HA H12N5 (A/green-winged teal/ALB/199/1991) HA H13N8 (A/black-headed gull/Netherlands/1/00) HA H15N8 (A/duck/AUS/341/1983) HA H16N3 (A/black-headed gull/Sweden/5/99) HA No cross-reactivity in WB with H1N1 (A/Victoria/4897/2022) HA Trimer H3N2 (A/Hong Kong/2671/2019) HA H3N2 (A/Hong Kong/1/1968) HA H5N1 (A/Indonesia/5/2005) HA |
| Verified Activity | 1. Anti-HA rabbit monoclonal antibody at 1:10000 dilution. -Sample: Recombinant Protein 10 ng -Lane 1: Influenza B (B/Florida/4/2006) HA -Lane 2: Influenza B (B/Brisbane/60/2008) HA -Lane 3: Influenza B (B/Colorado/06/2017) HA -Lane 4: Influenza B (B/PHUKET/3073/2013) HA -Lane 5: Influenza B (B/Washington/02/2019) HA -Lane 6: H1N1 (A/Brisbane/02/2018) HA -Lane 7: H1N1 (A/California/04/2009) HA -Lane 8: H1N1 (A/California/07/2009) HA -Lane 9: H1N1 (A/Guangdong-Maonan/SWL1536/2019) HA -Lane 10: H1N1 (A/Michigan/45/2015) HA -Lane 11: H1N1 (A/Puerto Rico/8/1934) HA -Lane 12: H1N1 (A/Victoria/4897/2022) HA Protein -Lane 13: H1N1 (A/Victoria/4897/2022) HA Trimer Protein -Lane 14: H1N1 (A/Wisconsin/588/2019) / (A/Victoria/2570/2019) HA -Lane 15: H1N1 (A/Wisconsin/67/2022) HA Protein -Lane 16: H1N1 (A/Wisconsin/67/2022) HA Trimer Protein -Lane 17: H3N2 (A/Brisbane/10/2007) HA -Lane 18: H3N2 (A/Cambodia/e0826360/2020) HA -Lane 19: H3N2 (A/Darwin/6/2021) HA Protein -Lane 20: H3N2 (A/Hong Kong/1/1968) HA Protein -Lane 21: H3N2 (A/Hong Kong/45/2019) HA -Lane 22: H3N2 (A/Hong Kong/4801/2014) HA -Lane 23: H3N2 (A/Kansas/14/2017) HA -Lane 24: H3N2 (A/Singapore/INFIMH-16-0019/2016) HA -Lane 25: H3N2 (A/Switzerland/9715293/2013) HA -Lane 26: H3N2 (A/Hong Kong/2671/2019) HA -Lane 27: H5N1 (A/Indonesia/5/2005) HA Protein -Secondary -Goat Anti-Rabbit IgG (H+L)/HRP at 1/10000 dilution. -Developed using the ECL technique. -Performed under reducing conditions. 2. Anti-HA rabbit monoclonal antibody at 1:1000 dilution. -Sample: Recombinant Protein 10 ng -Lane A: H3N2 (A/Darwin/9/2021) HA Protein -Lane B: H3N2 (A/Darwin/9/2021) HA Protein -Lane C: H3N2 (A/Darwin/6/2021) HA Protein -Lane D: Influenza B (B/Austria/1359417/2021)(Victoria lineage) HA Protein -Lane E: Influenza B (B/Austria/1359417/2021)(Victoria lineage) HA Protein -Secondary -Goat Anti-Rabbit IgG (H+L)/HRP at 1/10000 dilution -Developed using the ECL technique. -Performed under reducing conditions. |
| Application | |
| Recommended Dose | WB: 1:2000-1:20000; ELISA: 1:5000-1:10000 |
| Antibody Type | Monoclonal |
| Host Species | Rabbit |
| Construction | This antibody was obtained from a rabbit immunized with purified, recombinant Influenza B Hemagglutinin (TMPY-00955; ACA33493.1; Met 1-Ala 555) . |
| Purification | Protein A |
| Appearance | Liquid |
| Formulation | 0.2 μm filtered solution in PBS |
| Research Background | The influenza viral Hemagglutinin (HA) protein is a homotrimer with a receptor binding pocket on the globular head of each monomer.HA has at least 18 different antigens. These subtypes are named H1 through H18.HA has two functions. Firstly, it allows the recognition of target vertebrate cells, accomplished through the binding to these cells' sialic acid-containing receptors. Secondly, once bound it facilitates the entry of the viral genome into the target cells by causing the fusion of the host endosomal membrane with the viral membrane. The influenza virus Hemagglutinin (HA) protein is translated in cells as a single protein, HA, or hemagglutinin precursor protein. For viral activation, hemagglutinin precursor protein (HA) must be cleaved by a trypsin-like serine endoprotease at a specific site, normally coded for by a single basic amino acid (usually arginine) between the HA1 and HA2 domains of the protein. After cleavage, the two disulfide-bonded protein domains produce the mature form of the protein subunits as a prerequisite for the conformational change necessary for fusion and hence viral infectivity. |
| Conjucates | Unconjugated |
| Immunogen | Recombinant Protein: Influenza B virus HA protein (TMPY-00955) |
| Antigen Species | Influenza B |
Stability & Storage
| Stability & Storage | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
| Transport | Shipping with blue ice. |
Calculator
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . 
Sci Citations
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Anti-Influenza B (B/Florida/04/06) Hemagglutinin/HA Antibody (5D484) | purchase Anti-Influenza B (B/Florida/04/06) Hemagglutinin/HA Antibody (5D484) | Anti-Influenza B (B/Florida/04/06) Hemagglutinin/HA Antibody (5D484) cost | order Anti-Influenza B (B/Florida/04/06) Hemagglutinin/HA Antibody (5D484)
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.